Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now later-stage tilt small index

Strabismus: later-stage trial registry

4 of 10 indexed Strabismus trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #1,724 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

10 US clinical trials · 4 currently recruiting · #1,724 of 28,707 conditions by registered trial count

Strabismus: 10 US clinical trials tracked, 4 recruiting.

Strabismus is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is National Eye Institute (NEI), running 2 of these trials.

Enrollment posture brief

Registry condition strabismus

OPEN 4 | RECR 40% | LATE 1 | EARLY 0 | RANK #1724 | SPON 2

Volume-matched condition peers

Nearest open-share peer: Acute Myeloid Leukemia (AML) (40% recruiting · 30 trials)

Acute Leukemia of Ambiguous 80%Achondroplasia40%Strabismus (this)40%Accelerated Phase Chronic My20%Accidental Fall20%
Open-enrollment share among volume-matched conditions near Strabismus

Strabismus lists 4 open slots (40% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Strabismus on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Strabismus is recruiting below its size-band peers.

    4 of 10 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Strabismus research.

    National Eye Institute (NEI) accounts for 2 of 10 trials (20%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Typical Strabismus enrolment sits around 150 participants.

    Median target enrolment is 150 among the 10 trials that report a genuine target (sentinel values excluded). 5 of those (50%) plan for fewer than 100 participants.

  4. Strabismus research leans observational.

    2 interventional and 8 observational studies make up this index (20% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Top Sponsors

National Eye Institute (NEI) 2 trials
Duke University 2 trials
Alaska Blind Child Discovery 1 trials
Rebiscan 1 trials
Massachusetts Eye and Ear Infirmary 1 trials
The University of Texas Health Science Center, Houston 1 trials
The Cleveland Clinic 1 trials
Boston Children's Hospital 1 trials

Named interventions

Most-linked intervention names on Strabismus records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

subtenons control - 0.5 cc of Normal Saline Drug
1 trials
topical control - 0.5 cc of Hypromellose 0.3% gel Drug
1 trials
topical anesthetic - 0.5 cc of lidocaine 3.5% ophthalmic gel Drug
1 trials
subtenons anesthetic - preservative-free bupivacaine 0.75% Drug
1 trials
Pediatric Vision Scanner eye scan Device
1 trials
Patch Device
1 trials
Atropine Drug
1 trials
Microscope integrated optical coherence tomography Device
1 trials

US sites by state

Facility locations filed on Strabismus trials. A trial with sites in several states counts in each.

North Carolina 2 trials
Maryland 2 trials
Massachusetts 2 trials
Texas 1 trials
Ohio 1 trials
California 1 trials
Alaska 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Strabismus page

10 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Strabismus condition card totals 10 registered trials; most-linked intervention subtenons control - 0.5 cc of Normal Saline; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.